Premium
Pulmonx Corporation (LUNG)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.73 | 24.8920863309 | 6.95 | 9.37 | 6.495 | 1076407 | 8.52928484 | CS |
| 4 | 2.37 | 37.559429477 | 6.31 | 9.37 | 5.57 | 426051 | 7.80198269 | CS |
| 12 | 2.17 | 33.3333333333 | 6.51 | 9.37 | 5.57 | 302651 | 7.09513434 | CS |
| 26 | 1.17 | 15.5792276964 | 7.51 | 9.37 | 5.57 | 263867 | 7.12223873 | CS |
| 52 | -2.06 | -19.1806331471 | 10.74 | 11.1 | 5.46 | 364671 | 7.65709199 | CS |
| 156 | -16.37 | -65.3493013972 | 25.05 | 28.3 | 4.07 | 390777 | 11.61641892 | CS |
| 260 | -29.32 | -77.1578947368 | 38 | 69.4779 | 4.07 | 375481 | 20.24208995 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
